PULSE BIOSCIENCES, INC.
Company Stats
- Market Cap
- $3.6B
- as of Sep 30, 2026
- Shares Outstanding
- 71.3M
- Free Float
- 23.0%
Income Statement
- Revenue
- $350,000
- Operating Income
- -$76.9M
- Net Income
- -$72.8M
- EBITDA
- -$76.5M
- Revenue Growth, 3Y
- -20.6%
Cash Flow
- Free Cash Flow
- -$54.4M
- FCF Yield
- -1.5%
- Owner FCF Yield
- -2.1%
Balance Sheet
- Cash & Equivalents
- $80.7M
Returns & Capital
- SBC, 3Y Avg
- $14.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $350,000 | -$54.4M | -15553.4% |
| FY2024 | $0 | -$36.5M | — |
| FY2023 | $0 | -$33.2M | — |
| FY2022 | $700,000 | -$47.4M | -6773.4% |
| FY2021 | $1.4M | -$54.5M | -3845.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 13, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges